• Home
  • About Atom
    • Management Team
    • Advisory Board
    • Investors
  • Our Programs
    • Pipeline
    • Gout & Hyperuricemia
    • NASH
  • News & Events
  • Contact Us

Post navigation

Previous PostBioWorld: Atom Bioscience Planning Phase III Gout Trial After Encouraging Mid-Stage Readout
Next Post

Follow us on

  • Home
  • About Atom
  • Our Programs
  • News & Events
  • Contact Us

©2023 Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.